High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
2020-04-16

2020. Jeong HY, Kim HJ, Kim CE, Lee S, Choi MC, Kim SH. The International Journal of Neuroscience 1‐8.